Investinor
Government organization
Active
Trondheim, Norway
118
4M
84
7.38
50
0.28
10
- Stages of investment
- Areas of investment
Summary
Investinor appeared to be the VC, which was created in 2008. The company was established in Europe in Norway. The leading representative office of defined VC is situated in the Trondheim.
The fund has no specific favorite in a number of founders of portfolio startups. When startup sums 4 or 5+ of the founder, the probability for it to get the investment is little. For fund there is a match between the location of its establishment and the land of its numerous investments - Norway. Besides, a startup requires to be at the age of 6-10 years to receive the investment from the fund. Among the most successful fund investment fields, there are SaaS, Health Care. Among the most popular portfolio startups of the fund, we may highlight poLight, APIM Therapeutics, Skitude.
The standard case for the fund is to invest in rounds with 1-2 partakers. Despite the Investinor, startups are often financed by Alliance Venture, ProVenture Management, Sarsia Seed Management. The meaningful sponsors for the fund in investment in the same round are ProVenture Management, Viking Venture Management, Target Partners. In the next rounds fund is usually obtained by Alliance Venture, Viking Venture Management, Target Partners.
The overall number of key employees were 10.
The fund is constantly included in 7-12 deals per year. The increased amount of exits for fund were in 2017. This Investinor works on 20 percentage points less the average amount of lead investments comparing to the other organizations. The top activity for fund was in 2018. Despite it in 2019 the fund had an activity. Considering the real fund results, this VC is 43 percentage points more often commits exit comparing to other organizations. The common things for fund are deals in the range of 5 - 10 millions dollars.
Investor highlights
- Stage focus
Discover reliable insights
Find relevant VC investors, identify key contacts and secure funding opportunities.
Investments analytics
Analytics
- Total investments
- 118
- Lead investments
- 50
- Exits
- 10
- Rounds per year
- 7.38
- Follow on index
- 0.28
- Investments by industry
- Software (33)
- Information Technology (22)
- Biotechnology (15)
- Manufacturing (13)
- Oil and Gas (13) Show 123 more
- Investments by region
-
- Norway (105)
- United States (8)
- Switzerland (1)
- United Kingdom (2)
- Peak activity year
- 2018
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 12
- Avg. valuation at time of investment
- 5M
- Group Appearance index
- 0.62
- Avg. company exit year
- 10
- Avg. multiplicator
- 2.86
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Calluna Pharma | 23 Jan 2024 | Biotechnology, Pharmaceutical | Early Stage Venture | 88M | Oslo, Norway |
| Full Speed | 13 May 2005 | Marketing, Advertising, Ad Network, SEO, SEM | Seed | 109K | Japan, Chiyoda |
| Numascale | 02 Sep 2009 | Application Software, Application Specific Semiconductors, Big Data, Data Center, Semiconductor, Field-Programmable Gate Array (FPGA) | Early Stage Venture | 4M | Oslo, Norway |
Similar funds
By same location
By same geo focus
By doing lead investments
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.